HALO Past Earnings image   This HALO past earnings page last updated 8/11/2022
HALO Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/9/20220.530
Q1 20225/10/20220.470
Q4 20212/22/20220.420
Q3 202111/2/20210.550
Q2 20218/9/20210.660
Q1 20215/10/20210.370
Q4 20202/23/20210.500
Q3 202011/2/20200.250
Q2 20208/10/20200.190
Q1 20205/11/2020-0.040
Q4 20192/24/2020-0.240
Q3 201911/12/2019-0.170
Q2 20198/6/2019-0.100
Q1 20195/7/20190.010
Q4 20182/21/2019-0.01
Q3 201811/6/2018-0.19
Q2 20188/7/2018-0.16
Q1 20185/10/2018-0.19
Q4 20172/20/20180.85
Q3 201711/7/20170.02
Q2 20178/8/2017-0.23
Q1 20175/9/2017-0.26
Q4 20162/28/2017-0.21
Q3 201611/7/2016-0.23
Q2 20168/9/2016-0.21
Q1 20165/9/2016-0.16
Q4 20152/29/20160.03
Q3 201511/9/2015-0.19
Q2 20158/10/20150.02
Q1 20155/11/2015-0.12
Q4 20143/2/2015-0.04
Q3 201411/10/2014-0.16
Q2 20148/11/2014-0.13
Q1 20145/12/2014-0.22
Q4 20132/27/2014-0.19
Q3 201311/8/2013-0.170
Q2 20138/7/2013-0.2
Q1 20135/8/2013-0.17
Q4 20122/25/2013-0.04
Q3 201211/8/2012-0.18
Q2 20128/6/2012-13
Q1 20125/7/2012-0.14
HALO Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/9/20220.15B
Q1 20225/10/20220.12B
Q4 20212/22/20220.10B
Q3 202111/2/20210.12B
Q2 20218/9/20210.14B
Q1 20215/10/20210.09B
Q4 20202/23/20210.12B
Q3 202011/2/20200.07B
Q2 20208/10/20200.06B
Q1 20205/11/20200.03B
Q4 20192/24/20200.05B
Q3 201911/12/20190.05B
Q2 20198/6/20190.04B
Q1 20195/7/20190.06B
Q4 20182/21/201960.23M
Q3 201811/6/201825.56M
Q2 20188/7/201835.20M
Q1 20185/10/201830.87M
Q4 20172/20/2018189.56M
Q3 201711/7/201763.73M
Q2 20178/8/201733.75M
Q1 20175/9/201729.57M
Q4 20162/28/201739.00M
Q3 201611/7/201631.85M
Q2 20168/9/201633.34M
Q1 20165/9/201642.50M
Q4 20152/29/201652.23M
Q3 201511/9/201520.78M
Q2 20158/10/201543.38M
Q1 20155/11/201518.67M
Q4 20143/2/201530.38M
Q3 201411/10/201414.60M
Q2 20148/11/201414.61M
Q1 20145/12/201411.97M
Q4 20132/27/20140.01B
Q3 201311/8/20130.02B
Q2 20138/7/201314.50M
Q1 20135/8/201311.80M
Q4 20122/25/201321.79M
Q3 201211/8/20125.30M
Q2 20128/6/20127.76M
Q1 20125/7/20127.44M
Quotes delayed 20 minutes

Email EnvelopeFree HALO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Halozyme Therapeutics (HALO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

HARP Past Earnings
HBIO Past Earnings
HCA Past Earnings
HCWB Past Earnings
HEPA Past Earnings
HGEN Past Earnings
HJLI Past Earnings
HNGR Past Earnings
HOLX Past Earnings
HOOK Past Earnings

HALO Past Earnings Q&A

What was the best and worst HALO past earnings results?
For Halozyme Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest HALO past earnings result in our data set was 0.85/share posted in Q4 2017, while the lowest was in Q2 2012 when HALO posted -13/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2017 when HALO reported 189.56M in revenue, while the quarter with the lowest revenue in our data set was Q3 2012 at 5.30M of revenue.

  Suggested answer: There are 42 HALO past earnings results in our data set.

On this page we presented the HALO past earnings date information for Halozyme Therapeutics. Reviewing that HALO Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2017, when HALO posted adjusted EPS of 0.85/share. Meanwhile the lowest HALO past earnings result was in Q2 2012, when HALO posted adjusted EPS of -13/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2017 when HALO reported 189.56M in revenue, while the smallest revenue quarter was Q3 2012 when HALO reported 5.30M in revenue.

Any self directed investor doing their due diligence on HALO or any other given stock can benefit from researching all of the Halozyme Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Halozyme Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for HALO. Thanks for visiting, and the next time you need to research HALO past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: MBTC shares outstanding history, DIA Historical Stock Prices, Funds Holding MDP.

 

HALO Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.